Stock info Bioera | Filter  Basic-Info

Stock: Bioera (Italian market)

Last Price 0.04 Max Price 0.10
Min Price 0.03 1 Year return -87.10
Sector Health Care Subsector Pharmaceuticals
Annual report 2013

Loading...

Contact info:Street: Via Palestro, 6Zip Code: 20121City: MilanoCountry: ItalyPhone: 02-36695124Email: segreteria@bioera.itWebsite: www.bioera.iCEO: Canio Giovanni MazzaroCFO: Francesca Cesari

Sector Review Bioera

Loading...
Year Turnover Total sector Market share
2019 32 615,670 0.01 %
2020 12 638,104 0.00 %
2021 1 727,997 0.00 %
2022 1 787,317 0.00 %
2023 0 0 0.00 %

Advice Bioera

No Records Found




News Bioera

No Records Found

Annual reports Bioera

2017 2018 2019 2020 2021

Profile Bioera

Bioera

/ BIEm

Bioera's headquarter is based in Milano. Bioera mainly operates in the pharmaceutical sector. Canio Giovanni Mazzaro is leading the company as CEO. The CFO of Bioera the company is Francesca Cesari. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year yielded positive returns for Bioera investors

Over the past year the company' stock lost around 38 percent. The period between August 2011 and August 2016 was a bad period for the investors. The stock lost around 17 percent. Bioera's revenues between 2011 and 2015 were relatively steady and moved between 47,16 million euros and 58,49 million euros. During 2011 and 2015 Bioera's net results were very volatile and fluctuated between 11,36 million euros and 0 million euros.

Over the past 5 years the Italian company paid out dividends. On average Bioera's dividend yield over the past 5 years was around 0,05 percent annually.

Bioera financed with relatively low debt

At the end of 2015 the Italian company's balance sheet was worth 0 million euros. The total debt was around 0 million euros. This is percent of the total balance sheet.

The pharmaceutical company's market capitalization (the number of shares outstanding times the market value) equaled around 0 million euros.

All Bioera's annual reports can be found here. More information about Bioera can be found it's website. .


Results Bioera

Results
2015
2016
2017
2018
2019
2020
Revenue
58
54
47
41
32
12
Costs
62
57
52
45
38
15
Profit
-3
-3
-5
-4
-6
-3
Margin of profit
-5.78
-5.13
-10.93
-8.77
-18.69
-23.25
ROI
-27.48
-23.60
-68.39
-71.88
70.99
24.58

Balance Bioera

Balance
2015
2016
2017
2018
2019
2020
Equity
12
12
8
5
-8
-11
Debt
29
29
27
25
30
28
Total assets
41
41
34
30
22
17
Solvency
29.72
28.80
22.04
16.99
-38.99
-67.05
Cash
1
4
1
1
0
Cashflow
-1
-1
-2
0
1
-3
Employees
0
0
0
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-0.04
-0.04
-0.06
0.0
0.04
-0.09

Details Bioera

Details
2016
2017
2018
2019
2020
Price
26.83
15.05
13.42
4.20
4.86
Eps
-5.67
-10.23
-5.85
-8.17
-2.29
Price/earnings-ratio
-4.73
-1.47
-2.29
-0.51
-0.02
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
24.04
13.48
7.39
-10.82
-6.91
Market to book
0.90
0.90
0.55
-2.58
-172.75
Cashflow per stock
-2.56
-3.01
0.04
1.60
-1.63
Stocks
0
1
1
1
2
Market Cap
13.19
8.41
9.16
3.26
0.06

Dividend Bioera


Price info Bioera

Date
Price
17 Dec 2024
0.04
10 Dec 2024
0.04
06 Dec 2024
0.04
03 Dec 2024
0.04
29 Nov 2024
0.04
27 Nov 2024
0.04
13 Nov 2024
0.06
08 Nov 2024
0.06
05 Nov 2024
0.06
31 Oct 2024
0.06
29 Oct 2024
0.06
23 Oct 2024
0.06
19 Oct 2024
0.07
16 Oct 2024
0.06
14 Oct 2024
0.06
05 Oct 2024
0.06
02 Oct 2024
0.06
27 Sep 2024
0.06
20 Sep 2024
0.06
17 Sep 2024
0.06
13 Sep 2024
0.07
28 Aug 2024
0.07
26 Aug 2024
0.07
23 Aug 2024
0.07
11 Aug 2024
0.07
07 Aug 2024
0.07
05 Aug 2024
0.06
01 Aug 2024
0.07
30 Jul 2024
0.07
26 Jul 2024
0.08